Aristea Kalikaki

University of Crete — Greece

Medicine · Health Sciences

7h-index685citations15works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(7), Lung Cancer Treatments and Mutations(5), Cancer Genomics and Diagnostics(4), Cancer Cells and Metastasis(2), Gastric Cancer Management and Outcomes(2)

Publications15 total

Long-term clinical benefit from salvage EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer patients with EGFR wild-type tumors
Clinical & Translational Oncology·2017· 3 cited
Next generation sequencing identifies actionable mutations in EGFR-wild type and KRAS mutant non-small cell lung cancer patients
Annals of Oncology·2016Open Access
P-028 Analysis of KRAS and NRAS mutations in Greek patients with metastatic Colorectal Cancer (mCRC) on the registry of the Gastro-intestinal Cancer Study Group (GIC-SG)
Annals of Oncology·2016Open Access
<i>ERCC1</i>SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy
Cancer Investigation·2015· 14 cited
KRAS Genotypic Changes of Circulating Tumor Cells during Treatment of Patients with Metastatic Colorectal Cancer
PLoS ONE·2014· 45 citedOpen Access
Comparison of Kras Mutation Status Between Primary Tumors and Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer (MCRC)
Annals of Oncology·2013
Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer
Modern Pathology·2012· 53 citedOpen Access
Association of PIK3CA kinase domain mutations with poor prognosis in operable breast cancer.
Journal of Clinical Oncology·2011
Impact of <i>KRAS, BRAF</i>, and <i>PIK3CA</i> mutations, PTEN, <i>AREG,</i> and <i>EREG</i> expression, and skin rash in metastatic colorectal cancer patients treated with cetuximab-containing salvage treatment.
Journal of Clinical Oncology·2011· 1 cited
Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in ≥2nd Line Cetuximab-Based Therapy of Colorectal Cancer Patients
PLoS ONE·2011· 125 citedOpen Access
Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status
Lung Cancer·2009· 88 cited
DNA Repair Gene Polymorphisms Predict Favorable Clinical Outcome in Advanced Non–Small-Cell Lung Cancer
Clinical Lung Cancer·2009· 149 cited
Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC
British Journal of Cancer·2008· 207 citedOpen Access
W01.21 Effects of anti-TNF therapy on endothelial function and intima-media thickness of common carotid artery in patients with rheumatoid arthritis (RA)
Atherosclerosis Supplements·2004
Effects of anti-TNF therapy on endothelial function and intima–media thickness of common carotid artery in patients with rheumatoid arthritis
Arthritis Research·2004Open Access

Frequent Co-authors

Alexandra Voutsina(11), Vassilis Georgoulias(9), John Souglakos(7), Anastasios Koutsopoulos(5), Dimitris Mavroudis(5), Maria Tzardi(5), Maria Sfakianaki(5), Maria Trypaki(4), E. Tsakalaki(4), Efstathios N. Stathopoulos(3), Chara Papadaki(3), D. Mavroudis(3), D. Mavroudis(2), Zacharenia Saridaki(2), Fraga Pega(2), Helen Politaki(2), E. Papadimitraki(2), Αthanasios Kotsakis(2), Sofia Agelaki(2), Emmanuel S. Ganotakis(2)